Acid Reducer and Ibritumomab Intravenous
Determining the interaction of Acid Reducer and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranitidine
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acid Reducer-Ibritumomab Tiuxetan
- Acid Reducer-Ibrutinib
- Acid Reducer-Ibrutinib Capsules
- Acid Reducer-Ibrutinib Tablets
- Acid Reducer-Ibu
- Acid Reducer-IBU Tablets
- Ibritumomab Intravenous-Acid Relief
- Ibritumomab Intravenous-Aciphex
- Ibritumomab Intravenous-Aciphex (Rabeprazole Delayed-Release Tablets)
- Ibritumomab Intravenous-Aciphex (Rabeprazole Sprinkle Capsules)
- Ibritumomab Intravenous-AcipHex Sprinkle
- Ibritumomab Intravenous-Acitretin